Pulse pressure is not an independent predictor of incident atrial fibrillation in 60-year-old men and women

References

• Markides V, Schilling RJ. Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart. 2003;89:939–43.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–52.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840–4.
   PubMed Web of Science ®Google Scholar
• Safar ME, Nilsson PM, Blacher J, Mimran A. Pulse pressure, arterial stiffness, and end-organ damage. Curr Hypertens Rep. 2012;14:339–44.
   PubMed Web of Science ®Google Scholar
• Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395–401.
   PubMed Web of Science ®Google Scholar
• Vaccarino V, Berger AK, Abramson J, Black HR, Setaro JF, Davey JA, et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol. 2001;88:980–6.
   PubMed Web of Science ®Google Scholar
• Ciaroni S, Bloch A, Lemaire MC, Fournet D, Bettoni M. Prognostic value of 24-hour ambulatory blood pressure measurement for the onset of atrial fibrillation in treated patients with essential hypertension. Am J Cardiol. 2004;94:1566–9.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Dagenais G, Healey J, Gao P, Dans AL, Chazova I, et al. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies. J Hypertens. 2012;30:1004–14.
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA. 2007;297:709–15.
   PubMed Web of Science ®Google Scholar
• Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, et al. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. Hypertension. 2012;60:347–53.
   PubMed Web of Science ®Google Scholar
• Valbusa F, Bonapace S, Bertolini L, Zenari L, Arcaro G, Targher G. Increased pulse pressure independently predicts incident atrial fibrillation in patients with type 2 diabetes. Diabetes Care. 2012;35:2337–9.
   PubMed Web of Science ®Google Scholar
• Roetker NS, Chen LY, Heckbert SR, Nazarian S, Soliman EZ, Bluemke DA, et al. Relation of systolic, diastolic, and pulse pressures and aortic distensibility with atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2014;114:587–92.
   PubMed Web of Science ®Google Scholar
• Halldin M, Rosell M, de Faire U, Hellenius ML. The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women. Nutr Metab Cardiovasc Dis. 2007;17:349–57.
   PubMed Web of Science ®Google Scholar
• Ahmad Y, Lip GY, Lane DA. Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. Can J Cardiol. 2013;29(7 Suppl):S4–13.
   PubMed Web of Science ®Google Scholar
• Halldin M, Fahlstadius P, de Faire U, Vikstrom M, Hellenius ML. The metabolic syndrome and left ventricular hypertrophy–the influence of gender and physical activity. Blood Press. 2012;21:153–60.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
   PubMed Web of Science ®Google Scholar
• Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3:e003423.
   PubMed Web of Science ®Google Scholar
• Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100:354–60.
   PubMed Web of Science ®Google Scholar
• Winston GJ, Palmas W, Lima J, Polak JF, Bertoni AG, Burke G, et al. Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Hypertens. 2013;26:636–42.
   PubMed Web of Science ®Google Scholar
• Friberg J, Scharling H, Gadsboll N, Truelsen T, Jensen GB, Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol. 2004;94:889–94.
   PubMed Web of Science ®Google Scholar
• Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1998;32:560–4.
   PubMed Web of Science ®Google Scholar
• Glynn RJ, Chae CU, Guralnik JM, Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Arch Intern Med. 2000;160:2765–72.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Corbucci G, Padeletti L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol. 2012;110:270–6.
   PubMed Web of Science ®Google Scholar
• Forslund T, Wettermark B, Wandell P, von Euler M, Hasselstrom J, Hjemdahl P. Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system. Int J Cardiol. 2013;170:208–14.
   PubMed Web of Science ®Google Scholar